IL-31 anticorps
Aperçu rapide pour IL-31 anticorps (ABIN6964030)
Antigène
Voir toutes IL-31 (IL31) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Specificité
- Native and recombinant human IL-31
-
Purification
- Purified from in vitro cultures by protein G affinity chromatography.
-
Immunogène
- Recombinant human IL-31
-
Isotype
- IgG1
-
-
-
-
Indications d'application
- Neutralization of human IL-31 bioactivity. It is recommended to establish the optimal antibody concentration for the assay system used. Neutralization Neutralization assay: Neutralization of human IL-31 induced IL-6 production (see graph). To determine the neutralizing capacity and ND50, mixtures of human recombinant IL-31 (50 ng/ ml) and various concentrations of mAb MT313 were added to human aortic endothelial cells that had been pre-stimulated with recombinant human IFN-γ (10 ng/mL). Following overnight incubation, cell supernatants were quantified in IL-6 ELISA. Neutralization dose 50 (ND50): MT313 neutralized the effect of human IL-31 at a ND50value of 0.1-0.6 μg/mL when 50 ng/mL of human IL-31 was present. ND50 is defined as the concentration of antibody that results in 50 % inhibition of the biological response under the experimental conditions specified.
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 1 mg/mL
-
Buffer
- supplied at 1 mg/mL in PBS free of preservatives
-
Agent conservateur
- Without preservative
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- Store product at 4-8°C or frozen at -20°C or below. Avoid repeated freezing/thawing.
-
Date de péremption
- 18 months
-
-
- IL-31 (IL31) (Interleukin 31 (IL31))
-
Autre désignation
- IL31
-
ID gène
- 386653
Antigène
-